Literature DB >> 31537368

Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017.

Hebe N Gouda1, Fiona Charlson2, Katherine Sorsdahl3, Sanam Ahmadzada4, Alize J Ferrari2, Holly Erskine2, Janni Leung2, Damian Santamauro2, Crick Lund5, Leopold Ndemnge Aminde6, Bongani M Mayosi7, Andre Pascal Kengne8, Meredith Harris4, Tom Achoki9, Charles S Wiysonge10, Dan J Stein11, Harvey Whiteford2.   

Abstract

BACKGROUND: Although the burden of disease in sub-Saharan Africa continues to be dominated by infectious diseases, countries in this region are undergoing a demographic transition leading to increasing prevalence of non-communicable diseases (NCDs). To inform health system responses to these changing patterns of disease, we aimed to assess changes in the burden of NCDs in sub-Saharan Africa from 1990 to 2017.
METHODS: We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to analyse the burden of NCDs in sub-Saharan Africa in terms of disability-adjusted life-years (DALYs)-with crude counts as well as all-age and age-standardised rates per 100 000 population-with 95% uncertainty intervals (UIs). We examined changes in burden between 1990 and 2017, and differences across age, sex, and regions. We also compared the observed NCD burden across countries with the expected values based on a country's Socio-demographic Index.
FINDINGS: All-age total DALYs due to NCDs increased by 67·0% between 1990 (90·6 million [95% UI 81·0-101·9]) and 2017 (151·3 million [133·4-171·8]), reflecting an increase in the proportion of total DALYs attributable to NCDs (from 18·6% [95% UI 17·1-20·4] to 29·8% [27·6-32·0] of the total burden). Although most of this increase can be explained by population growth and ageing, the age-standardised DALY rate (per 100 000 population) due to NCDs in 2017 (21 757·7 DALYs [95% UI 19 377·1-24 380·7]) was almost equivalent to that of communicable, maternal, neonatal, and nutritional diseases (26 491·6 DALYs [25 165·2-28 129·8]). Cardiovascular diseases were the second leading cause of NCD burden in 2017, resulting in 22·9 million (21·5-24·3) DALYs (15·1% of the total NCD burden), after the group of disorders categorised as other NCDs (28·8 million [25·1-33·0] DALYs, 19·1%). These categories were followed by neoplasms, mental disorders, and digestive diseases. Although crude DALY rates for all NCDs have decreased slightly across sub-Saharan Africa, age-standardised rates are on the rise in some countries (particularly those in southern sub-Saharan Africa) and for some NCDs (such as diabetes and some cancers, including breast and prostate cancer).
INTERPRETATION: NCDs in sub-Saharan Africa are posing an increasing challenge for health systems, which have to date largely focused on tackling infectious diseases and maternal, neonatal, and child deaths. To effectively address these changing needs, countries in sub-Saharan Africa require detailed epidemiological data on NCDs. FUNDING: Bill & Melinda Gates Foundation, National Health and Medical Research Centre (Australia).
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31537368     DOI: 10.1016/S2214-109X(19)30374-2

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  159 in total

1.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Association between white matter hyperintensities and stroke in a West African patient population: Evidence from the Stroke Investigative Research and Educational Network study.

Authors:  Jingfei Li; Godwin Ogbole; Benjamin Aribisala; Murtala Affini; Joseph Yaria; Issa Kehinde; Mukaila Rahman; Fakunle Adekunle; Rasaq Banjo; Moyinoluwalogo Faniyan; Rufus Akinyemi; Bruce Ovbiagele; Mayowa Owolabi; Steffen Sammet
Journal:  Neuroimage       Date:  2020-04-07       Impact factor: 6.556

Review 3.  Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study.

Authors:  Gabriel Chamie; Matthew D Hickey; Dalsone Kwarisiima; James Ayieko; Moses R Kamya; Diane V Havlir
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

4.  Noncommunicable Diseases: Yet Another Challenge for Human Immunodeficiency Virus Treatment and Care in Sub-Saharan Africa.

Authors:  Brian K Agan; Vincent C Marconi
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

5.  Socioeconomic inequality in tobacco use in Kenya: a concentration analysis.

Authors:  Hermann Pythagore Pierre Donfouet; Shukri F Mohamed; Eric Malin
Journal:  Int J Health Econ Manag       Date:  2021-01-04

6.  Evaluating the availability of essential drugs for hypertension, diabetes and asthma in rural Rwanda, 2018.

Authors:  F Mbonyinshuti; K C Takarinda; S Ade; M Manzi; P G Iradukunda; J Kabatende; T Habiyaremye; P C Kayumba
Journal:  Public Health Action       Date:  2021-03-21

7.  Developmental Origins of Health and Disease: Impact of environmental dust exposure in modulating microbiome and its association with non-communicable diseases.

Authors:  Delicia Shu-Qin Ooi; Cheryl Pei-Ting Tan; Michelle Jia-Yu Tay; Siong Gim Ong; Elizabeth Huiwen Tham; Kewin Tien Ho Siah; Johan Gunnar Eriksson; Keith M Godfrey; Lynette Pei-Chi Shek; Evelyn Xiu-Ling Loo
Journal:  J Dev Orig Health Dis       Date:  2020-06-15       Impact factor: 2.401

8.  Risk factors and outcomes of hospitalized stroke patients in Lusaka, Zambia.

Authors:  Aparna Nutakki; Mashina Chomba; Lorraine Chishimba; Stanley Zimba; Rebecca F Gottesman; Mona N Bahouth; Deanna Saylor
Journal:  J Neurol Sci       Date:  2021-03-18       Impact factor: 3.181

Review 9.  Retinol, Retinoic Acid, and Retinol-Binding Protein 4 are Differentially Associated with Cardiovascular Disease, Type 2 Diabetes, and Obesity: An Overview of Human Studies.

Authors:  Thomas Olsen; Rune Blomhoff
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

10.  Prevalence and sociodemographic correlates of diabetes among adults in Namibia and South Africa.

Authors:  Aprill Z Dawson; Rebekah J Walker; Jennifer A Campbell; Joni S Williams; Leonard E Egede
Journal:  J Natl Med Assoc       Date:  2021-06-25       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.